Marie-Eve Muller
Overview
Explore the profile of Marie-Eve Muller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suter A, Muller M, Daccord C, Taffe P, Lazor R
Orphanet J Rare Dis
. 2023 Jul;
18(1):180.
PMID: 37415209
Background: Sporadic lymphangioleiomyomatosis (S-LAM) is a rare low-grade neoplasm of young women characterized by multiple pulmonary cysts leading to progressive dyspnea and recurrent spontaneous pneumothorax (SP). The diagnosis of S-LAM...
2.
Zanchi A, Pruijm M, Muller M, Ghajarzadeh-Wurzner A, Maillard M, Dufour N, et al.
Front Cardiovasc Med
. 2022 Apr;
9:854230.
PMID: 35391843
Background: Sodium-glucose co-transport 2 inhibitors (SGLT2i) lower blood pressure (BP) in normotensive subjects and in hypertensive and normotensive diabetic and non-diabetic patients. However, the mechanisms of these BP changes are...
3.
Harmacek D, Pruijm M, Burnier M, Muller M, Ghajarzadeh-Wurzner A, Bonny O, et al.
J Am Soc Nephrol
. 2022 Apr;
33(6):1073-1075.
PMID: 35387874
Empagliflozin and Renal Oxygenation in Healthy Volunteers (EMPA-REIN), NCT03093103.
4.
Muller M, Daccord C, Taffe P, Lazor R
Front Med (Lausanne)
. 2021 May;
8:631168.
PMID: 33987191
Birt-Hogg-Dubé syndrome (BHD) is a rare inherited disorder characterized by cutaneous fibrofolliculomas, multiple pulmonary cysts, recurrent spontaneous pneumothorax (SP), and renal tumors. More than 40 years after its description, the...
5.
Muller M, Rusca S, Lazor-Blanchet C
Rev Med Suisse
. 2020 Oct;
16(709):1881-1885.
PMID: 33026732
Prevalence of burnout in physicians is increasing, affecting their health and satisfaction at work as well as quality and security of healthcare. Several causes have been identified, of which growing...
6.
Zanchi A, Burnier M, Muller M, Ghajarzadeh-Wurzner A, Maillard M, Loncle N, et al.
J Am Heart Assoc
. 2020 Jun;
9(13):e016173.
PMID: 32567439
Background The sodium/glucose cotransporter 2 inhibitor empagliflozin has cardiorenal protective properties through mechanisms beyond glucose control. In this study we assessed whether empagliflozin modifies renal oxygenation as a possible mechanism...
7.
Braconnier P, Piskunowicz M, Vakilzadeh N, Muller M, Zurcher E, Burnier M, et al.
Acta Radiol
. 2019 May;
61(1):117-127.
PMID: 31091970
No abstract available.
8.
Muller M, Pruijm M, Bonny O, Burnier M, Zanchi A
Adv Ther
. 2018 May;
35(6):875-885.
PMID: 29802538
Introduction: Empagliflozin is an SGLT-2 inhibitor (SGLT-2i) which belongs to a new class of hypoglycemic drugs with the unique property of decreasing blood glucose independently from insulin, through an increase...
9.
Vakilzadeh N, Muller M, Forni V, Milani B, Hoffman L, Piskunowicz M, et al.
Kidney Blood Press Res
. 2015 Oct;
40(5):542-54.
PMID: 26501147
Background/aims: The purpose of the present study was to compare the direct renin inhibitor aliskiren to the diuretic hydrochlorothiazide (HCTZ) in their ability to modulate renal tissue oxygenation in hypertensive...
10.
Muller M, Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, et al.
Pflugers Arch
. 2015 Jun;
467(12):2413-21.
PMID: 26089029
Interactions between sodium and calcium regulating systems are poorly characterized but clinically important. Parathyroid hormone (PTH) levels are increased shortly after furosemide treatment by an unknown mechanism, and this effect...